Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic decision-making: a model for formulary evaluation.

G P Sesin

    Drug Intelligence & Clinical Pharmacy
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mesalamine-associated pleural effusion with pulmonary infiltration.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998
    Same author

    New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1996
    Same author

    Ticarcillin-clavulanate as an alternative to imipenem-cilastatin.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1995
    Same author

    Evaluation of i.v. ceftriaxone usage in a community-based hospital.

    Hospital formulary·1993
    Same author

    Evaluation of the use of i.v. ciprofloxacin.

    Hospital formulary·1992
    Same author

    Imipenem/cilastatin drug utilization evaluation in a large community hospital.

    DICP : the annals of pharmacotherapy·1991

    This study proposes a future-focused approach to hospital formulary decisions. Selecting medications based on clinical indications, rather than cost or class, ensures optimal therapeutic use and reduced overall expenses.

    Area of Science:

    • Health Economics
    • Pharmacology
    • Hospital Administration

    Background:

    • Hospital formularies are crucial for managing medication selection and use.
    • The increasing number of new therapeutic agents necessitates forward-thinking formulary strategies.
    • Current formulary decisions may not always optimize clinical and economic outcomes.

    Purpose of the Study:

    • To present a systematic approach for evaluating medications for hospital formulary inclusion.
    • To advocate for a method of medication selection that prioritizes clinical indications.
    • To demonstrate how indication-based selection can improve therapeutic utilization and reduce costs.

    Main Methods:

    • Discussion of a systematic evaluation process for hospital formulary medications.

    Related Experiment Videos

  • Presentation of examples illustrating indication-based selection criteria.
  • Comparative analysis of indication-based selection versus selection by drug cost or pharmacologic class.

    • Main Results:

    • Choosing medications based on clinical indications is identified as the most effective strategy.
    • This approach supports both clinical efficacy and economic efficiency.
    • Examples of indication-based selection criteria are provided to support the proposed method.

    Conclusions:

    • Selecting formulary agents by clinical indication is superior to simple drug cost or pharmacologic class.
    • This strategy ensures more effective utilization of therapeutic agents.
    • The indication-based approach is expected to lead to a reduction in overall healthcare costs.